Group items tagged

Pharmacy Business and Haleon jointly hosted a practical Pain Management webinar on 5 December 2023. The webinar was specially designed to empower community pharmacies with effective strategies for understanding, managing, and reducing pain in their patients' daily life. Pharmacist Faheem Ahmend, director at Health Clinic & MEDLRN, and Linda Perry, account relationship manager OTC at Haleon, engaged in an insightful and informative conversation, highlighting real issues in the pharmacy setting and practical solutions to support community pharmacists.

Welcome to our comprehensive guide on understanding and managing musculoskeletal pain. This type of discomfort, often arising from an injury to the body's muscles, joints, tendons, ligaments, or nerves, can lead to significant functional impairment and reduced quality of life. In the following sections, we'll delve into the causes, diagnosis, and various treatment options for musculoskeletal pain, equipping you with the knowledge you need to manage and alleviate your symptoms effectively. Consult a Medical Professional While this guide offers a general understanding of musculoskeletal pain, it is critical to consult with a healthcare professional for any pain or discomfort you may be experiencing. Health practitioners can offer a proper diagnosis and develop a personalized treatment plan that considers your specific symptoms, condition, and overall health. For example, the best physical therapists can suggest a variety of exercises and stretches to help strengthen muscles and alleviate pain. Some pain may require surgery, while others can be managed with medication or physical therapy. Your medical provider will work with you to find the most effective treatment plan.

Amidst the pervasive prevalence of pain, with 93% of the global populace experiencing it annually and 1 in 3 enduring daily discomfort, there persists a reluctance to address and treat pain proactively. This leads to a heightened burden of suffering among individuals. Join us for an enlightening 1-hour Pain Management Webinar, meticulously crafted to equip you and your team with vital strategies to comprehend, manage, and alleviate pain in patients' daily lives. Delve into topics such as the pharmacist's evolving role, understanding pain assessment, and Haleon's #ListenToPain campaign, aimed at fostering better patient conversations. Tailored for pharmacists in GB dealing with acute or chronic pain, this webinar promises to enhance patient care and contribute positively to their well-being. Don't miss out on this opportunity to make a meaningful difference. Register now to secure your spot at this impactful event!

Consumer healthcare group Haleon on Thursday announced that it has entered into a binding agreement for the sale of the ChapStick brand to Suave Brands Company, a company owned by American private equity firm Yellow Wood Partners. The British consumer healthcare company has agreed to sell its lip balm brand to Suave for about $430 million in cash and a minority interest in the buyer, valued at around $80 million. Haleon, which was spun off from the GSK Group in July 2022, said that cash proceeds from the sale would be used to pay down debt. ChapStick generated £112 million ($142.5 million) in revenue in 2023, said Haleon, adding that the sale is likely to close in the second quarter of 2024. Brian McNamara, Chief Executive Officer, Haleon, said: "Today's announcement is consistent with Haleon being proactive in managing our portfolio, and being rigorous and disciplined where there are opportunities for divestment. "While ChapStick is a great brand, much loved by consumers around the world, it is not a core focus for Haleon.